Strontium ranelate (PROTELOS): new contra-indications and updated warnings

The European Medicines Agency confirms that the benefit / risk balance of strontium ranelate (PROTELOS in Belgium) remains positive. It recommends, however, that this medicine be contra-indicated in immobilised patients or patients with venous thromboembolism. It also updated the warnings regarding serious skin reactions.

See other languages: French or Dutch.

Contact
vig@fagg.be

 

Last updated on
02/04/2012